adenosine diphosphate has been researched along with Cardiovascular Stroke in 189 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 74 (39.15) | 18.7374 |
1990's | 29 (15.34) | 18.2507 |
2000's | 36 (19.05) | 29.6817 |
2010's | 41 (21.69) | 24.3611 |
2020's | 9 (4.76) | 2.80 |
Authors | Studies |
---|---|
Herbert, JM; Savi, P | 1 |
Aguiar, MO; Azevedo, L; Baracioli, LM; Berwanger, O; Chiang, HP; Dalcoquio, TF; de Luca, F; Ferrari, AG; Furtado, RHM; Giugliano, RP; Goodman, S; Lima, FG; Matthias, W; Menezes, FR; Nicolau, JC; Scanavini-Filho, MA | 1 |
Costa, TGR; Franken, M; Guerra, JCC; Katz, M; Lemos Neto, PA; Pesaro, AEP | 1 |
Fukushima, A; Fumoto, Y; Furihata, T; Hagiwara, H; Handa, H; Hata, S; Kakutani, N; Kang, D; Kinugawa, S; Maekawa, S; Masunaga, T; Nambu, H; Sabe, H; Setoyama, D; Takada, S; Ueda, K; Yokota, T | 1 |
Alves Dos Santos, M; Bittar Brito Arantes, F; Dalçóquio, TF; de Nazare Nunes Alves, MJ; Ferreira-Santos, L; Franci, A; Furtado, RHM; Gehlen Ferrari, A; Genestreti Rizzo, PR; Moreira Baracioli, L; Negrão, CE; Nicolau, JC; Pinto Brandão Rondon, MU; Salsoso, R; Silva Alves, L | 1 |
Chen, J; Su, C; Tian, M; Wu, C; Zhang, T; Zhang, Z | 1 |
Balanova, I; Bezak, B; Böhm, A; Danova, K; Dostalova, K; Jajcay, N; Kollarova, M; Lauko, V; Lazurova, L; Mojto, V; Moravcik, R; Petrikova, K; Slezak, P; Varga, I; Zeman, M | 1 |
Gager, GM; Hengstenberg, C; Jilma, B; Kolesnik, E; Lang, IM; Prüller, F; Siller-Matula, JM; Toma, A; von Lewinski, D; Wallner, M; Winter, MP | 1 |
Afanas'ev, SА; Golubenko, МV; Kercheva, МА; Muslimova, EF; Rebrova, ТY; Tsapko, LP | 1 |
Braun, D; Brunner, S; Deseive, S; Hagl, C; Hausleiter, J; Istrefi, M; Kellnar, A; Kika, S; Kleeberger, J; Krieg, K; Kupka, D; Lüsebrink, E; Massberg, S; Orban, M; Petzold, T; Scherer, C; Sibbing, D; Stark, K; Stocker, TJ; Würbel, S | 1 |
Deppen, J; García, AJ; Levit, RD; Shin, EY; Strobel, F; Tirouvanziam, R; Wang, L; Xu, K; Zemskova, M | 1 |
Dai, S; Jia, Q; Jiang, J; Lv, L; Wang, J; Wang, S; Wang, Y | 1 |
Lei, H; Liu, Q; Luo, S | 1 |
Anderson, EJ; Blanton, HD; DeAntonio, JH; Ding, JM; Johnson, TL; Kent, SD; Lust, RM; Moukdar, F; Thayne, K; Virag, JA | 1 |
de Wijs-Meijler, D; Duncker, DJ; Jan Danser, AH; Jankowski, J; Jankowski, V; Lankhuizen, I; Merkus, D; Zhou, Z | 1 |
Bracy, DP; Hughey, CC; James, FD; Ma, L; Rottman, JN; Shearer, J; Wang, Z; Wasserman, DH | 1 |
Banerjee, D; Bhattacharya, R; Ghosh, R; Jana, P; Ray, U; Sinha, A | 1 |
Dalén, M; Holm, M; Tornvall, P; van der Linden, J | 1 |
Feng, ZH; He, X; Jiang, HK; Sun, L; Wang, YH; Yu, XJ; Zang, WJ; Zhao, M | 1 |
Duraj, L; Fedor, M; Fedorová, J; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M; Šimonová, R; Škorňová, I; Staško, J | 1 |
Abendschein, D; Broekman, MJ; Chen, R; Drosopoulos, JH; Jeong, SS; Marcus, AJ; Moeckel, D; Nguyen, A; Robson, SC; Sun, X | 1 |
Andruszkiewicz, A; Fabiszak, T; Kasprzak, M; Koziński, M; Kubica, A; Kubica, J; Obońska, K; Paciorek, P; Pio Navarese, E; Siller-Matula, J; Swiątkiewicz, I; Sztuba, B | 1 |
Franskavichene, LV; Golukhova, EZ; Serebruany, VL; Syvolap, VV | 1 |
Fabiszak, T; Grześk, G; Kasprzak, M; Koziński, M; Kubica, A; Kubica, J; Laskowska, E; Navarese, EP; Obońska, K; Świątkiewicz, I; Sztuba, B | 1 |
Baaten, CC; Crijns, H; de Witt, SM; Heemskerk, JW; Henskens, YM; Nylander, S; Swieringa, F; van der Meijden, PE; van Geffen, JP; van Giezen, JJ; Veenstra, LF; Wetzels, R | 1 |
Grześk, G; Kasprzak, M; Kubica, A; Kubica, J; Obońska, K; Ostrowska, M; Stolarek, W; Wiciński, M | 1 |
Anderson, RA; Freeman, PM; Hinz, C; James, PE; Kinnaird, TD; Moschonas, KE; O'Donnell, VB | 1 |
Iannone, P | 1 |
Nikolaou, NI; Welsford, M; Woolfrey, KG | 1 |
Ju, L; Li, J; Liu, X; Wang, L; Wang, Y; Zhang, M | 1 |
Gao, RL; He, C; Liu, R; Ma, YL; Meng, XM; Song, L; Song, Y; Tang, XF; Wang, M; Xu, JJ; Yao, Y; Yuan, JQ; Zhang, JH | 1 |
Anstrom, KJ; Baker, BA; Cohen, DJ; Effron, MB; Henry, TD; McCoy, LA; Messenger, JC; Peterson, ED; Wang, TY; Zettler, ME | 1 |
Bagatini, MD; Battisti, V; dos Santos, RB; Gasparetto, D; Gonçalves, JF; Martins, CC; Morsch, VM; Rosa, CS; Schetinger, MR; Spanevello, RM | 1 |
Tang, SW; Wang, HT; Wu, XL; Wu, YL; Zhang, HX; Zhang, YF; Zhu, HM | 1 |
Greyson, CR | 1 |
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giglioli, C; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Valente, S | 1 |
Antonino, MJ; Bassi, AK; Bliden, KP; DiChiara, J; Gesheff, TB; Gurbel, PA; Hennebry, TA; Herzog, WR; Mahla, E; Saucedo, JF; Singla, A; Suarez, TA; Tantry, US | 1 |
Bazhenova, EA; Berkovich, OA; Shvartsman, AL; Sirotkina, OV; Vavilova, TV; Zabotina, AM | 1 |
Angiolillo, DJ; Antman, EM; Braunwald, E; Downey, WE; Frelinger, AL; Jakubowski, JA; Li, Y; McCabe, CH; Michelson, AD; Murphy, SA; Qin, J; Wiviott, SD; Xenopoulos, NP | 1 |
Badimon, JJ; Burg, MM; Chaplin, W; Davidson, KW; Fuster, V; Paz-Yepes, M; Shimbo, D; Vilahur, G; Zafar, MU | 1 |
Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kwak, CH; Lee, SW; Park, SW; Park, Y | 1 |
Jannati, M; Khalili, A; Kojuri, J; Mahboodi, A; Mahmoody, Y; Zangbar Sabegh, B | 1 |
He, Y; Lu, S; Ruan, C; Zhang, Y; Zhao, Y; Zhu, M | 1 |
Fefer, P; Hod, H; Matetzky, S; Novikov, I; Savion, N; Shechter, M; Shenkman, B; Varon, D | 1 |
Bordel, V; Bruckner, B; Ghodsizad, A; Gregoric, I; Kallenbach, K; Karck, M; Kögler, G; Niehaus, M; Ruhparwar, A; Ungerer, MN | 1 |
Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kim, S; Koh, EH; Kwak, CH; Park, JR; Park, KS; Park, Y; Yun, SE | 1 |
Anzaha, G; Barthélémy, O; Bellemain-Appaix, A; Beygui, F; Caron, C; Cayla, G; Chastre, T; Collet, JP; Galier, S; Gallois, V; Hulot, JS; Montalescot, G; Pena, A; Silvain, J; Vignalou, JB | 1 |
Behr, T; Behr, W; Kuch, B; von Scheidt, W | 1 |
Barone, L; Battipaglia, I; Coviello, I; Crea, F; De Nisco, A; Delogu, A; Di Monaco, A; Infusino, F; Lanza, GA; Romagnoli, C; Scalone, G; Sestito, A | 1 |
Andreotti, F; Bielis, L; Boinska, J; Grabczewska, Z; Kozinski, M; Kubica, A; Kubica, J; Marciniak, A; Navarese, EP; Rosc, D; Siller-Matula, JM; Stolarek, W; Wisniewska-Szmyt, J | 1 |
Bouman, HJ; Breet, NJ; Hackeng, CM; Kelder, JC; ten Berg, JM; van Werkum, JW | 1 |
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Migliorini, A; Parodi, G; Valenti, R | 1 |
Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kwak, CH; Kwon, TJ; Park, Y; Yun, SE | 1 |
Agha, A; Carmody, D; Foley, DP; Kavanagh, GF; Kenny, D; Mylotte, D; O'Reilly, M; Peace, AJ; Smith, D; Tedesco, AF; Thompson, CJ | 1 |
Bouman, HJ; de Maat, MP; Hackeng, CM; Leebeek, FW; Rudež, G; ten Berg, JM; ten Cate, H; van Werkum, JW | 1 |
Abbate, R; Antoniucci, D; Gensini, GF; Giglioli, C; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Parodi, G; Saracini, C; Valente, S | 1 |
Ge, J; Qian, J; Sun, A; Wang, Q; Wu, H | 1 |
Alexopoulos, D; Damelou, A; Davlouros, P; Gkizas, V; Hahalis, G; Theodoropoulos, KC; Tsigkas, G; Xanthopoulou, I | 1 |
Chen, YF; Ge, ZD; Gross, GJ; Li, PL; Zou, AP | 1 |
Aggarwal, A; Gennari, FJ; Kabbani, SS; Rimmer, JM; Schneider, DJ; Sobel, BE; Taatjes, DJ | 1 |
Chen, Y; Davis-Gorman, G; McDonagh, PF; Watson, RR | 1 |
Headrick, JP; Peart, J | 1 |
Devaki, T; Ebenezar, KK; Sathish, V | 1 |
Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP | 1 |
Théroux, P; Xiao, Z | 1 |
Beinart, R; Bienart, R; Goldenberg, I; Guetta, V; Hod, H; Matetzky, S; Novikov, I; Pres, H; Savion, N; Shechter, M; Shenkman, B; Varon, D | 1 |
Domanovits, H; Frossard, M; Fuchs, I; Hsieh, K; Jilma, B; Laggner, AN; Leitner, JM; Losert, H; Schreiber, W; Vlcek, M | 1 |
Almsherqi, ZA; Deng, Y; Kocherginsky, N; Kostetski, I; Liu, SL; McLachlan, CS; Mossop, P; Navet, R; Shi, DY; Slocinska, MB; Sluse, FE | 1 |
Bache, RJ; Bransford, TL; Feygin, J; From, AH; Hu, Q; Lee, J; Liu, J; Mansoor, A; Ochiai, K; Swingen, C; Wang, X; Zeng, L; Zhang, G; Zhang, J | 1 |
Bal-dit-Sollier, C; Beygui, F; Collet, JP; Drouet, L; Henry, P; Lellouche, N; Meuleman, C; Milleron, O; Montalescot, G; Sideris, G; Slama, M; Steg, PG | 1 |
Cicha, I; Daniel, WG; Garlichs, CD; Klinghammer, L; Lohmann, T; Raaz, D; Stumpf, C; Wallaschofski, H; Yilmaz, A | 1 |
Alessi, MC; Bali, L; Bonnet, JL; Cuisset, T; Frere, C; Lambert, M; Mielot, C; Morange, PE; Nait-Saidi, L; Quilici, J | 1 |
Bareiss, P; Chauvin, M; Desprez, D; Faure, A; Grunebaum, L; Jesel, L; Morel, O; Ohlmann, P; Roul, G; Viellard, C | 1 |
Cerletti, C; Costanzo, S; de Gaetano, G; Iacoviello, L; Izzi, B; Pampuch, A; Vohnout, B | 1 |
Filipiak, KJ; Grabowski, M; Huczek, Z; Kochanowski, J; Kochman, J; Opolski, G; Piatkowski, R; Roik, M | 1 |
Carr, CA; Clarke, K; Cole, MA; Little, SE; Lygate, CA; Murray, AJ; Neubauer, S; Stuckey, DJ | 1 |
Bedja, D; Borgonjon, DJ; Champion, HC; Claeys, MJ; Cos, P; Elsaesser, RS; Gabrielson, KL; Haile, A; Kaminski, PM; Kass, DA; Lazzarino, G; Moens, AL; Paolocci, N; Tavazzi, B; Timmermans, JP; Van Nassauw, L; Vrints, CJ; Wolin, MS; Wuyts, FL; Zviman, M | 1 |
Begent, NA; Born, GV; Görög, P | 1 |
Kuroiwa, A; Nakashima, Y; Takahara, K; Takasugi, M; Takei, S | 1 |
Kelton, JG | 1 |
Bulatova, TP; Chetverikova, EP; Dzgoeva, ZU; Rozanova, NA | 1 |
Stoltz, JF | 1 |
Maddox, WT; McDaniel, HG; Poon, MC; Rackley, CE; Rogers, WJ | 1 |
Hattori, S; Miyazaki, T; Mori, H; Nagata, M; Nakamura, Y; Ogawa, S; Sakurai, K; Takahashi, M | 1 |
Sapozhkov, AV; Sysoliatina, NA | 1 |
de la Morena García, E; González Isabel, C | 1 |
Hultman, J; Ronquist, G | 1 |
Bonfiglioli, D; Cialfi, A; Fasoli, A; Gandini, R; Garimoldi, M; Panigo, FE; Rovelli, L; Sommariva, D | 1 |
Amtorp, O; Gormsen, J; Knudsen, JB; Skagen, K | 1 |
Hayet, M; Letac, B; Peugnet, JP; Piguet, H; Toussaint, C | 1 |
Braunwald, E; DeBoer, LW; Ingwall, JS; Kloner, RA | 1 |
Dormandy, JA | 1 |
Heptinstall, S | 1 |
Frishman, WH | 1 |
Chitre, AP; Velaskar, DS | 1 |
Born, GV; Kratzer, MA | 1 |
Crome, R; Grannell, J; Hearse, DJ; Wyse, RK; Yellon, DM | 1 |
Heptinstall, S; Mitchell, JR; Mulley, GP; Taylor, PM | 1 |
Agnelli, G; Callegari, P; Hauert, J; Iorio, A; Parise, P | 1 |
Kemp, GJ; Radda, GK; Rajagopalan, B; Thompson, CH | 1 |
Friedrich, J; Gaudron, P; Horn, M; Hu, K; Ingwall, JS; Laser, M; Naumann, A; Neubauer, S; Schnackerz, K; Tian, R | 1 |
Edelman, ER; Friedman, M; Grossman, W; Harada, K; Sellke, FW; Simons, M; Wang, SY | 1 |
Chujo, M; Hori, M; Inoue, M; Kitakaze, M; Minamino, T; Mori, H; Morioka, T; Sato, H; Shinozaki, Y; Takashima, S | 1 |
Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Komamura, K; Minamino, T; Morioka, T; Node, K; Takeda, H | 1 |
Funaya, H; Hori, M; Kitakaze, M; Minamino, T; Mori, H; Node, K; Shinozaki, Y | 1 |
Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Kurihara, T; Minamino, T; Node, K; Ueda, Y | 1 |
Bahr, RD; Dalesandro, MR; Grabletz, LB; Gumbs, CI; Gurbel, PA; Ohman, EM; Serebruany, VL; Shustov, AR; Topol, EJ | 1 |
Nakajima, Y; Nakashima, M; Saniabadi, AR; Takeich, S; Umemura, K; Yukawa, N | 1 |
Bahr, RD; Gurbel, PA; Lowry, DR; O'Connor, CM; Serebruany, VL | 1 |
Kapelko, VI; Kuzmin, AI; Lakomkin, VL; Vassort, G | 1 |
Gurbel, PA; Ohman, EM; Serebruany, VL; Shustov, AR; Topol, EJ | 1 |
Bünger, R; Miki, T; Miura, T; Sakamoto, J; Shimamoto, K; Suzuki, K | 1 |
Bode, C; Kohler, B; Kübler, W; Moser, M; Nordt, TK; Peter, K; Ruef, J | 1 |
Eto, K; Isshiki, T; Ochiai, M; Ozaki, Y; Sato, T; Takeshita, S | 1 |
Goto, S; Hande, S; Ikeda, Y; Sakai, H | 1 |
D'Sa, S; Machin, SJ | 1 |
Fitzgerald, DJ; Quinn, MJ | 1 |
Apstein, CS | 1 |
Agneskirchner, J; Bode, PA; Reininger, AJ; Spannagl, M; Wurzinger, LJ | 1 |
Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K | 1 |
Gebauer, MU; Haeberli, A; Julmy, F; Meyer, BJ; Moshfegh, K; Redondo, M; Wuillemin, WA | 1 |
Goto, S; Handa, M; Ikeda, Y; Murata, M | 1 |
Beswick, A; Elwood, PC; Flower, RJ; McCarron, P; O'Brien, JR; Pickering, J; Renaud, SR | 1 |
Bache, RJ; Godinot, C; Gong, G; Ishibashi, Y; Liu, J; Murakami, Y; Ochiai, K; Prody, C; Wang, C; Zhang, J | 1 |
Ferguson, JJ; Kim, P; Villareal, RP; Wilson, JM | 1 |
Hasebe, N; Jin, YT; Kawabe, J; Kikuchi, K; Matsusaka, T | 1 |
Broniszewska-Ardelt, B; Ceremuzyński, L; Herbaczyńska-Cedro, K; Woźniewicz, B | 1 |
Davis, JW; Lin, CI; Phillips, PE; Yue, KT | 1 |
Born, GV; Wehmeier, A | 1 |
Agmon, J; Friedmann, J; Joshua, H; Rahamim, S; Weinberger, I | 1 |
Lukasiewicz, W; Mruk, J; Musial, J; Serwońska, M; Szczeklik, A | 1 |
Gryglewski, RJ; Moncada, S; Salmon, JA; Ubatuba, FB; Vane, JR; Weatherly, BC | 1 |
Sviridkina, LP | 1 |
Moschos, CB; Nussbaum, M | 1 |
Boisseau, M; Bouloumie, J; Bricaud, H; Broustet, JP; Emeriau, JP | 1 |
Guyton, JR; Willerson, JT | 1 |
Bygdeman, S; Eliasch, H | 1 |
Arkel, YS; Haft, JI | 1 |
Jones, CE; Parker, JC; Thomas, JX | 1 |
Barbieri, E; Dal Palù, C; Donadon, W; Pagnan, A; Tonolli, E | 1 |
Sheehy, TW | 1 |
Kolc, J; Kucerová, V; Málek, P | 1 |
Rees, BW | 1 |
Breddin, K; Krzywanek, HJ; Ziemen, M | 1 |
Dai, DZ; Rong, P; Zhang, JE | 1 |
Donas, A; Droudes, C; Evangelou, A; Tselepis, AD; Tsoukatos, D | 1 |
Wilhelmsen, L | 1 |
Biagetti, L; Caldarera, CM; Cattabriga, I; Colì, G; Finelli, C; Galeazzi, M; Guarnieri, C; Muscari, C; Turinetto, B | 1 |
Aminlari, M; Rezaian, GR | 1 |
Diodati, J; Lacoste, L; Lam, JY; Latour, JG; Théroux, P; Waters, D | 1 |
Fears, R; Ferres, H; Greenwood, HC | 1 |
Abe, S; Arima, S; Atsuchi, Y; Hamasaki, S; Maruyama, I; Nomoto, K; Okino, H; Tahara, M; Tanaka, H; Yamaguchi, H | 1 |
Bril, A; Man, RY; Maupoil, V; Opie, LH; Rochette, L; Verry, A | 1 |
Atakha ova, LE; Katsenovich, ER; Mazurov, AV; Repin, VS | 1 |
Cronberg, S; Holan, J; Kubisz, P; Parizek, M; Seghier, F | 1 |
de Faire, U; Hamsten, A; Nilsson, J; Svensson, J | 1 |
Collen, D; Coller, BS; Finkelstein, D; Gimple, LW; Gold, HK; Johns, JA; Leinbach, RC; Werner, W; Yasuda, T; Ziskind, AA | 1 |
Kendrew, PJ; Nidorf, SM; Strophair, J; Sturm, M; Taylor, RR | 1 |
Johansson, S; Kutti, J; Vedin, A; Vilén, L; Wadenvik, H; Wilhelmsson, C | 1 |
Faul, C; Jaschonek, K; Karsch, KR; Renn, W; Tidow, S; Weisenberger, H | 1 |
Bugriĭ, EM; Karpov, IuA; Kiktev, VG; Kuz'min, AV; Men'shikov, MIu | 1 |
Brezinski, D; Czeisler, CA; Gleason, RE; Muller, JE; Rutherford, JD; Schafer, AI; Tofler, GH; Williams, GH; Willich, SN | 1 |
Abbud, A; Dudaev, VA; Ivanov, AS | 1 |
Hill, ML; Jennings, RB; Murry, CE; Reimer, KA; Yamasawa, I | 1 |
Gratsianskiĭ, NA; Men'shikov, MIu; Panchenko, EP; Shalaev, SV; Tkachuk, VA | 1 |
Kutti, J; Swedberg, K; Vedin, A; Vilén, L | 1 |
Cronberg, S; Johansson, S; Kutti, J; Vedin, A; Vilén, L; Wilhelmsson, C | 1 |
Holliss, DG; Humphrey, SM; Seelye, RN | 1 |
Hoak, JC; Wu, KK | 1 |
Paterson, RA | 1 |
Hampton, JR; Mitchell, JR | 1 |
Pavlishchuk, SA; Petrova, TR | 1 |
Laprevote-Heully, MC; Larcan, A; Nicolas, A; Stoltz, JF | 1 |
Bicher, HI; Kuperminc, M | 1 |
Hampton, JR; Mitchell, JR; Nicholls, DG | 1 |
Kevorkov, AI; Krivenko, VV | 1 |
Hampton, JR; Nicholls, DG | 1 |
Gudbjarnason, S; Mathes, P; Ravens, KG | 2 |
Razumnaia, NM | 1 |
Dugdale, M; Salky, N | 1 |
Hemker, HC | 1 |
Gudbjarnason, S; Mathes, P | 1 |
Weiss, HJ | 1 |
Gorlin, R; Hampton, JR | 1 |
Opie, LH; Owen, P; Shulman, G; Thomas, M | 1 |
Gudbjarnason, S; Mathes, P; Puri, PS | 1 |
Gudbjarnason, S; Puri, PS | 1 |
11 review(s) available for adenosine diphosphate and Cardiovascular Stroke
Article | Year |
---|---|
P2Y12, a new platelet ADP receptor, target of clopidogrel.
Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Down-Regulation; Humans; Membrane Proteins; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine | 2003 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cerebrovascular Disorders; Collagen; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sex Factors; Sulfinpyrazone; Thrombosis | 1983 |
Electrochemical properties of platelets: clinical and pharmacological applications.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Cell Membrane; Collagen; Electrochemistry; Electrophoresis; Humans; Hydrogen-Ion Concentration; Myocardial Infarction; Norepinephrine; Osmolar Concentration; Phosphates; Platelet Aggregation; Polymers; Risk; Serotonin; Sialic Acids; Sulfhydryl Compounds; Surface Properties; Thrombin; Thrombosis | 1983 |
Haemorheological aspects of thrombosis.
Topics: Adenosine Diphosphate; Arteries; Blood Flow Velocity; Blood Viscosity; Erythrocytes; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis | 1980 |
Platelet behaviour and vascular disease.
Topics: Adenosine Diphosphate; Arachidonic Acids; Blood Platelets; Humans; Imidazoles; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Prognosis; Thrombosis; Vascular Diseases | 1980 |
Antiplatelet therapy in coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Thromboxane A2 | 1982 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine | 1999 |
Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury.
Topics: Adenosine Diphosphate; Animals; Fatty Acids, Nonesterified; Glucose; Glycolysis; Humans; Insulin; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Phosphorylation; Oxygen Consumption; Potassium | 2000 |
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor | 2000 |
Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy.
Topics: Adenosine Diphosphate; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Drug Therapy, Combination; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2001 |
Anticoagulants and Anticoagulation.
Topics: Adenosine Diphosphate; Anticoagulants; Blood Coagulation; Blood Coagulation Factors; Coumarins; Disseminated Intravascular Coagulation; Heart Valve Prosthesis; Hemostasis; Heparin; Humans; Intracranial Embolism and Thrombosis; Myocardial Infarction; Postoperative Care; Pulmonary Embolism; Rheumatic Heart Disease; Thromboembolism; Vitamin K | 1976 |
20 trial(s) available for adenosine diphosphate and Cardiovascular Stroke
Article | Year |
---|---|
Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction.
Topics: Adenosine Diphosphate; Clopidogrel; Humans; Microcirculation; Myocardial Infarction; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Ticagrelor | 2022 |
Effects of exercise on platelet reactivity after myocardial infarction: a randomized clinical trial.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors | 2023 |
Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxide.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Case-Control Studies; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasms; Nitric Oxide; Nitroprusside; Peptides | 2014 |
Monitoring the efficacy of ADP inhibitor treatment in patients with acute STEMI post-PCI by VASP-P flow cytometry assay.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Female; Flow Cytometry; Follow-Up Studies; Humans; Male; Microfilament Proteins; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Phosphoproteins; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2015 |
Switching from generic to brand clopidogrel in male patients after ST-elevated myocardial infarction.
Topics: Adenosine Diphosphate; Aspirin; Clopidogrel; Drug Substitution; Drug Therapy, Combination; Drugs, Generic; Epinephrine; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2014 |
Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Blood Coagulation; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12 | 2015 |
Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Blood Coagulation; Blood Platelets; Clopidogrel; Collagen; Drug Therapy, Combination; Eptifibatide; Female; Hemorheology; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Recombinant Proteins; Stents; Thrombelastography; Ticlopidine | 2009 |
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Cell Adhesion Molecules; Clopidogrel; Female; Humans; Male; Microfilament Proteins; Middle Aged; Myocardial Infarction; Phosphoproteins; Phosphorylation; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2009 |
Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patie
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Blood Vessel Prosthesis Implantation; Cells, Cultured; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2010 |
Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Coronary Artery Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Iran; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Assessment; Risk Factors; Sex Factors; Smoking; Stents; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2010 |
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Chi-Square Distribution; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Humans; Korea; Liver; Male; Middle Aged; Myocardial Infarction; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Regression Analysis; Risk Assessment; Risk Factors; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2011 |
High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).
Topics: Adenosine Diphosphate; Adult; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Artery Bypass; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Resistance; Female; France; Gene Dosage; Heterozygote; Homozygote; Humans; Male; Middle Aged; Myocardial Infarction; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Registries; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome | 2011 |
Pretreatment platelet reactivity contribution to residual, post-treatment platelet reactivity in prasugrel-treated and ticagrelor-treated patients.
Topics: Adenosine; Adenosine Diphosphate; Blood Platelets; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticagrelor; Time Factors; Treatment Outcome | 2013 |
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; CD40 Ligand; Clopidogrel; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2004 |
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) t
Topics: Acute Disease; Adenosine Diphosphate; Aged; Biomarkers; Clopidogrel; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Platelet Aggregation; Platelet Aggregation Inhibitors; Single-Blind Method; Ticlopidine; Troponin I | 2006 |
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
Topics: Adenosine Diphosphate; Adult; Aged; Antigens, CD; Aspirin; Blood; Clopidogrel; Collagen; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Humans; Middle Aged; Myocardial Infarction; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prospective Studies; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Tetraspanin 30; Ticlopidine | 2000 |
Heparin neutralizing activity and coronary artery disease.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation Factors; Clinical Trials as Topic; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Factor 4 | 1977 |
ADP-induced platelet aggregation and metoprolol treatment of myocardial infarction patients. A controlled study.
Topics: Adenosine Diphosphate; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Platelet Aggregation | 1985 |
Platelet aggregation in hyperadhesive states.
Topics: Abdomen; Adenosine Diphosphate; Benzoates; Blood Platelet Disorders; Clinical Trials as Topic; Collagen; Dose-Response Relationship, Drug; Humans; Indoles; Myocardial Infarction; Placebos; Platelet Adhesiveness; Postoperative Complications; Tetrazoles; Time Factors | 1974 |
158 other study(ies) available for adenosine diphosphate and Cardiovascular Stroke
Article | Year |
---|---|
Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor.
Topics: Adenosine Diphosphate; Aspirin; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome | 2022 |
Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure.
Topics: Acyl Coenzyme A; Adenosine Diphosphate; Aminolevulinic Acid; Energy Metabolism; Glutamates; Heart Failure; Heme; Humans; Ketoglutaric Acids; Myocardial Infarction; Oxidative Phosphorylation | 2022 |
Association between P2Y1 and P2Y12 polymorphisms and acute myocardial infarction and ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Blood Platelets; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic | 2023 |
In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus.
Topics: Adenosine Diphosphate; Blood Platelets; Diabetes Mellitus, Type 2; Humans; Melatonin; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors | 2023 |
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Cardiovascular Diseases; Clopidogrel; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prognosis; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Stroke; Survival Rate; Ticagrelor | 2020 |
Peculiarities of the Functional State of Mitochondria of Peripheral Blood Leukocytes in Patients with Acute Myocardial Infarction.
Topics: Adenosine Diphosphate; Case-Control Studies; Cell Fractionation; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Myocardial Infarction; Oxidative Phosphorylation; Oxygen Consumption | 2020 |
ADP-induced platelet reactivity and bleeding events in patients with acute myocardial infarction complicated by cardiogenic shock.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Blood Platelets; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Shock, Cardiogenic | 2022 |
Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Hydrogen Peroxide; Immunity, Innate; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Rats, Sprague-Dawley; Recovery of Function; Stem Cell Niche; Tissue Scaffolds | 2018 |
rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats.
Topics: Adenosine Diphosphate; Animals; beta-Thromboglobulin; Blood Platelets; Calcium; Coronary Thrombosis; Cyclic AMP; Electrocardiography; Heart Ventricles; Lampreys; Male; Myocardial Infarction; Myocardium; Oligopeptides; Platelet Adhesiveness; Platelet Aggregation; Rats, Sprague-Dawley; Recombinant Proteins; Serotonin | 2018 |
Correlation between serum adiponectin and risk factors in patients with coronary artery disease.
Topics: Adenosine Diphosphate; Adiponectin; Aged; Angina Pectoris; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2013 |
Cardioprotection via preserved mitochondrial structure and function in the mPer2-mutant mouse myocardium.
Topics: Adenosine Diphosphate; Animals; Apoptosis; Biomarkers; Blotting, Western; Disease Models, Animal; Female; Immunohistochemistry; Macrophages; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mitochondria, Heart; Mitochondrial Membranes; Mutation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neutrophil Infiltration; Oxidative Stress; Oxygen Consumption; Period Circadian Proteins; Reactive Oxygen Species | 2013 |
Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.
Topics: Adenosine A2 Receptor Antagonists; Adenosine Diphosphate; Animals; Coronary Vessels; Dinucleoside Phosphates; Heart; Myocardial Infarction; Myocardium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Pyridoxal Phosphate; Pyrimidines; Receptors, Purinergic; Receptors, Purinergic P1; Theophylline; Triazoles; Vasodilator Agents; Ventricular Remodeling | 2013 |
Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart.
Topics: Adenosine Diphosphate; Animals; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction | 2014 |
Point-of-care testing of clopidogrel-mediated platelet inhibition and risk for cardiovascular events after coronary angiography with or without percutaneous coronary intervention.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Angiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Patient Readmission; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Point-of-Care Systems; Predictive Value of Tests; Prospective Studies; ROC Curve; Stents; Survival Analysis; Thrombosis; Ticlopidine | 2014 |
Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: roles of mitochondrial network dynamics.
Topics: Adenosine Diphosphate; Animals; Dynamins; Extracellular Signal-Regulated MAP Kinases; GTP Phosphohydrolases; Heart; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Membrane Proteins; Mitochondria, Heart; Mitochondrial Dynamics; Mitochondrial Proteins; Myocardial Infarction; Oxygen Consumption; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Transcription Factors; Tumor Suppressor Protein p53 | 2014 |
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.
Topics: Adenosine Diphosphate; Animals; Apyrase; Clopidogrel; Coronary Circulation; Dogs; Fibrinolysis; Hemorrhage; Humans; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Piperazines; Platelet Aggregation; Prasugrel Hydrochloride; Risk Factors; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency | 2014 |
Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Clopidogrel; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors | 2014 |
Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction.
Topics: Adenosine Diphosphate; Clopidogrel; Female; Humans; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2015 |
Acetylsalicylic acid resistance risk factors in patients with myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; C-Reactive Protein; Drug Resistance; Female; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Risk Factors | 2015 |
Changes in platelet function independent of pharmacotherapy following coronary intervention in non-ST-elevation myocardial infarction patients.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Blood Platelets; Chromatography, Liquid; Clopidogrel; Electrodes; Female; Flow Cytometry; Humans; Luminescence; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; P-Selectin; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Tandem Mass Spectrometry; Ticlopidine | 2015 |
Concerns about 2015 ERC Guidelines on pre-hospital use of ADP-receptor antagonists in patients with STEMI (ACS 335).
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Hospitals; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists | 2016 |
Reply to 'Concerns about 2015 ERC Guidelines on pre-hospital use of ADP-receptor antagonists in patients with STEMI (ACS 335)'.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Hospitals; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists | 2016 |
Cigarette smoking might weaken the prognostic significance of cytochrome P450 2C19*2 polymorphism in acute myocardial infarction patients.
Topics: Adenosine Diphosphate; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Polymorphism, Genetic; Prognosis; Smoking; Survival Analysis | 2016 |
Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; China; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Receptors, Purinergic P2Y12; Thrombelastography; Ticlopidine | 2016 |
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after
Topics: Adenosine; Adenosine Diphosphate; Aged; Cardiovascular Diseases; Clopidogrel; Drug Substitution; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Patient Preference; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P1 Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Female; Humans; Hydrolysis; Male; Middle Aged; Myocardial Infarction; Ticlopidine | 2008 |
[Protective effect of Tongxinluo Ultramicro-pulverization on experimental myocardial infarction of rats].
Topics: Adenosine Diphosphate; Animals; Aspirin; Diltiazem; Drugs, Chinese Herbal; Female; Male; Medicine, Chinese Traditional; Myocardial Infarction; Platelet Aggregation; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazolium Salts | 2008 |
Letter by Greyson regarding article, "High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury".
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiotonic Agents; Coronary Occlusion; Drug Evaluation, Preclinical; Endothelium, Vascular; Folic Acid; Hyperhomocysteinemia; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Premedication; Prodrugs; Purines; Rats; Rats, Wistar | 2008 |
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Point-of-Care Systems; Predictive Value of Tests; Prospective Studies; Treatment Outcome | 2009 |
[Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases].
Topics: Adenosine Diphosphate; Adult; Alleles; Amino Acid Substitution; Blood Platelets; Female; Gene Frequency; Humans; Male; Mutation, Missense; Myocardial Infarction; Platelet Aggregation; Polymorphism, Single Nucleotide; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Risk Factors; Russia; Sex Factors | 2009 |
Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; Anxiety Disorders; Aspirin; Clopidogrel; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Serotonin; Ticlopidine | 2010 |
A high-throughput biotin-avidin-ELISA for studying expression of platelet membrane glycoproteins and its clinical application.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Avidin; Biomarkers; Biotin; Cerebral Hemorrhage; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Myocardial Infarction; Platelet Membrane Glycoproteins; Sensitivity and Specificity | 2010 |
Statins have an early antiplatelet effect in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Arachidonic Acid; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Pravastatin; Simvastatin | 2011 |
Transplanted human cord blood-derived unrestricted somatic stem cells preserve high-energy reserves at the site of acute myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biopsy; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Energy Metabolism; Humans; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Paracrine Communication; Swine; Ventricular Function, Left | 2011 |
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Drug Monitoring; Drug Resistance; Drug Substitution; Electrodes; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Stents; Tetrazoles; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Platelet reactivity and endothelial function in children of patients with early acute myocardial infarction.
Topics: Adenosine Diphosphate; Adolescent; Adult; Analysis of Variance; Antibodies, Monoclonal, Murine-Derived; Child; Endothelium, Vascular; Exercise Test; Female; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Pedigree; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Vascular Cell Adhesion Molecule-1; Vasodilation | 2011 |
Diurnal variation in platelet inhibition by clopidogrel.
Topics: Adenosine Diphosphate; Aged; Blood Platelets; Circadian Rhythm; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2011 |
The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Arachidonic Acid; Cohort Studies; Coronary Angiography; Female; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Prospective Studies; Risk Factors; Treatment Outcome; Vascular Patency | 2011 |
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angioplasty; Aspirin; Clopidogrel; Death; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Risk; Stents; Stroke; Thrombosis; Ticlopidine | 2011 |
The concordance and correlation of measurements by multiple electrode and light transmittance aggregometries based on the pre-defined cutoffs of high and low on-treatment platelet reactivity.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Reproducibility of Results; ROC Curve | 2012 |
Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Blood Glucose; Blood Platelets; Collagen; Diabetes Mellitus, Type 2; Epinephrine; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Severity of Illness Index; Survivors | 2012 |
The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.
Topics: Adenosine Diphosphate; Aged; Aspirin; Clopidogrel; Female; Follow-Up Studies; Genetic Variation; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Polymorphism, Single Nucleotide; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Software; Stents; Ticlopidine | 2012 |
High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Alleles; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Heparin; Heterozygote; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk; Survival Rate; Ticlopidine | 2012 |
Association of CYP2C19 genotype with periprocedural myocardial infarction after uneventful stent implantation in Chinese patients receiving clopidogrel pretreatment.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Aryl Hydrocarbon Hydroxylases; Asian People; Blood Platelets; Chi-Square Distribution; China; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stents; Thrombelastography; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Myocardial ischemia and reperfusion reduce the levels of cyclic ADP-ribose in rat myocardium.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; ADP-ribosyl Cyclase; Animals; Cyclic ADP-Ribose; Enzyme Activation; Hydrogen-Ion Concentration; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxygen; Rats; Rats, Wistar | 2002 |
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
Topics: Adenosine Diphosphate; Coronary Artery Disease; Female; Fibrinogen; Flow Cytometry; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Microscopy, Confocal; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Renal Dialysis; Risk Factors | 2002 |
Vitamin E attenuates myocardial ischemia-reperfusion injury in murine AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adenosine Diphosphate; Animals; Antioxidants; CD11b Antigen; Disease Models, Animal; Female; Heart Ventricles; Mice; Mice, Inbred C57BL; Models, Cardiovascular; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; P-Selectin; Platelet Aggregation; Reactive Oxygen Species; Risk Factors; Vitamin E | 2002 |
Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects.
Topics: Adenosine; Adenosine Diphosphate; Alkaloids; Animals; Benzophenanthridines; Calcium Channel Blockers; Decanoic Acids; Diazoxide; Enzyme Inhibitors; Hydroxy Acids; Hypoxanthine; Inosine; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Phenanthridines; Phenethylamines; Potassium Channels; Protein Kinase C; Receptors, Purinergic P2; Signal Transduction; Xanthine | 2003 |
Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amlodipine; Animals; Cardiovascular Agents; Drug Synergism; Isoproterenol; Lipid Metabolism; Male; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Oxidation-Reduction; Rats; Rats, Wistar; Succinic Acid | 2003 |
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Epinephrine; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Prospective Studies; Purinergic P2 Receptor Antagonists; Recurrence; Risk; Smoking; Stents; Ticlopidine; Treatment Outcome | 2004 |
Platelet function predicts myocardial damage in patients with acute myocardial infarction.
Topics: Abciximab; Adenosine Diphosphate; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiovascular Agents; Clopidogrel; Collagen; Comorbidity; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Ticlopidine; Tirofiban; Tyrosine; von Willebrand Factor | 2004 |
Reduced cardiac output is associated with decreased mitochondrial efficiency in the non-ischemic ventricular wall of the acute myocardial-infarcted dog.
Topics: Adenosine Diphosphate; Animals; Cardiac Output; Carrier Proteins; Dogs; Heart Ventricles; Ion Channels; Male; Mitochondria, Heart; Mitochondrial Proteins; Myocardial Infarction; Myocardial Ischemia; Reactive Oxygen Species; Uncoupling Protein 3 | 2006 |
Profound bioenergetic abnormalities in peri-infarct myocardial regions.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Blotting, Western; Citrate (si)-Synthase; Collagen; Coronary Circulation; Coronary Vessels; Energy Metabolism; Hemodynamics; Ligation; Magnetic Resonance Spectroscopy; Mitochondria, Heart; Myocardial Infarction; Myocardium; Myoglobin; Oxygen Consumption; Phosphocreatine; Swine; Ventricular Remodeling | 2006 |
Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; Blood Platelets; Coronary Disease; Female; Flow Cytometry; Humans; Leptin; Male; Myocardial Infarction; P-Selectin; Prolactin | 2006 |
High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Female; France; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prognosis; Prospective Studies; Research Design; Risk Factors; Stents; Syndrome; Ticlopidine; Time Factors; Troponin I | 2007 |
[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Blood Proteins; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Microfilament Proteins; Myocardial Infarction; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Ticlopidine | 2007 |
Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
Topics: Adenosine Diphosphate; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Blood Glucose; Blood Platelets; CD11b Antigen; Collagen; Female; Flow Cytometry; Humans; Leukotriene B4; Male; Middle Aged; Monocytes; Myocardial Infarction; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Count; Population Surveillance; Sex Factors | 2007 |
Prognostic significance of platelet function in the early phase of ST-elevation myocardial infarction treated with primary angioplasty.
Topics: Adenosine Diphosphate; Adrenergic Agonists; Aged; Blood Platelets; Collagen; Epinephrine; Female; Humans; In Vitro Techniques; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Activation; Stents; Thromboxane A2; Ventricular Function, Left | 2008 |
Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart.
Topics: Adenosine Diphosphate; Animals; Cardiac Output; Cell Respiration; Citrate (si)-Synthase; Coronary Circulation; Heart Failure; In Vitro Techniques; Ion Channels; Male; Mitochondria, Heart; Mitochondrial Proteins; Myocardial Infarction; Oxygen Consumption; Perfusion; Rats; Rats, Wistar; Ultrasonography; Uncoupling Protein 1 | 2008 |
High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiotonic Agents; Coronary Occlusion; Drug Evaluation, Preclinical; Endothelium, Vascular; Folic Acid; Hyperhomocysteinemia; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Premedication; Prodrugs; Purines; Rats; Rats, Wistar; Superoxides | 2008 |
Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
Topics: Adenosine Diphosphate; Aspirin; Carotid Artery Thrombosis; Cerebral Infarction; Coronary Circulation; Coronary Disease; Hemodynamics; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation | 1984 |
Platelet aggregation in variant angina: its relation to plasma catecholamines.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris, Variant; Catecholamines; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Receptors, Adrenergic, alpha | 1984 |
[Determination of creatine phosphokinase activity in the blood serum].
Topics: Adenosine Diphosphate; Adenylate Kinase; Clinical Enzyme Tests; Colorimetry; Creatine Kinase; Enzyme Activation; Humans; Mercaptoethanol; Myocardial Infarction; Substrate Specificity; Time Factors | 1980 |
Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Female; Humans; In Vitro Techniques; Male; Myocardial Infarction; Platelet Aggregation; Thromboxane B2; Time Factors | 1983 |
Protection of hypoxic myocardium by intracoronary administration of verapamil in open-chest dogs.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Dogs; Energy Metabolism; Hemodynamics; Lactates; Lactic Acid; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption; Perfusion; Pyruvates; Pyruvic Acid; Verapamil | 1984 |
[Comparative characteristics of the effect of long-term beta-adrenostimulation and beta-adrenoblockade on myocardial metabolism in experimental myocardial infarction].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Dogs; Female; Male; Myocardial Infarction; Myocardium; Nonachlazine; Phenothiazines; Propranolol; Stimulation, Chemical; Time Factors | 1983 |
Variations of 2,3-biphosphoglycerate (2,3-BPG) with oxygen therapy.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Diphosphoglyceric Acids; Humans; Male; Myocardial Infarction; Oxygen Inhalation Therapy; Pneumonia | 1983 |
Myocardial high-energy phosphates and function under different postischemic conditions. A study in a paracorporeal rat heart model.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Coronary Circulation; Creatine Kinase; Extracorporeal Circulation; Isoenzymes; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption; Perfusion; Phosphocreatine; Phosphoenolpyruvate; Rats; Rats, Inbred Strains | 1984 |
Effect of D-glucitol-hexanicotinate on platelet aggregability in patients with coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Coronary Disease; Epinephrine; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Platelet Aggregation; Sorbitol | 1984 |
Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction.
Topics: Adenosine Diphosphate; Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Platelets; Collagen; Epinephrine; Factor VIII; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Serotonin; Serum Globulins; Time Factors | 1980 |
[Platelet aggregation in the acute phase of myocardial infarction].
Topics: Acute Disease; Adenosine Diphosphate; Adult; Aged; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation | 1980 |
Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biopsy; Dogs; Hypoxanthines; Inosine; Myocardial Infarction; Myocardium; Necrosis; Purines | 1980 |
A new aspect of platelet aggregation and a test to measure it.
Topics: Adenosine Diphosphate; Adult; Blood Platelet Disorders; Blood Platelets; Contraceptive Agents, Female; Diabetes Mellitus; Epinephrine; Evaluation Studies as Topic; Female; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Count; Uremia | 1982 |
Contribution of blood platelets to the pathogenesis of myocardial infarction.
Topics: Adenosine Diphosphate; Blood Platelets; Coronary Disease; Hemodynamics; Humans; Myocardial Infarction; Platelet Aggregation | 1981 |
Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Dogs; Lactates; Myocardial Infarction; Myocardium; Phosphocreatine | 1981 |
Platelet-release reaction in myocardial infarction.
Topics: Adenosine Diphosphate; Age Factors; Aged; Blood Platelets; Citrates; Female; Humans; Hydroxybutyrate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Prognosis; Serotonin; Sex Factors | 1980 |
Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cell Adhesion Molecules; Fibrinogen; Flow Cytometry; Humans; Myocardial Infarction; P-Selectin; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Activation; Platelet Membrane Glycoproteins; Recombinant Proteins; Recurrence; Serotonin; Streptokinase; Thrombin; Thrombolytic Therapy; Thromboxane A2 | 1995 |
Metabolic abnormalities in skeletal muscle after myocardial infarction in the rat.
Topics: Adenosine Diphosphate; Animals; Female; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mitochondria, Muscle; Muscle, Skeletal; Myocardial Infarction; Myocardium; Phosphocreatine; Physical Conditioning, Animal; Rats; Rats, Wistar | 1994 |
Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Citrate (si)-Synthase; Creatine Kinase; Energy Metabolism; Glycolysis; Hypoxia; In Vitro Techniques; Isoenzymes; Magnetic Resonance Spectroscopy; Myocardial Contraction; Myocardial Infarction; Oxygen Consumption; Perfusion; Phosphates; Phosphocreatine; Rats; Stress, Physiological; Ventricular Pressure | 1995 |
Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Alginates; Animals; Arginine; Calcimycin; Coronary Circulation; Coronary Vessels; Drug Carriers; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Glucuronic Acid; Heart; Hexuronic Acids; Indomethacin; Ketanserin; Male; Microcirculation; Muscle Relaxation; Myocardial Infarction; Myocardium; Nitroarginine; Nitroprusside; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Sepharose; Serotonin; Swine; Thromboxane A2; Vasodilation | 1994 |
Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Dogs; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Time Factors | 1994 |
Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Animals; Cytosol; Dogs; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Recurrence; Time Factors | 1996 |
Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cardiotonic Agents; Dipyridamole; Dogs; Enzyme Activation; Enzyme Inhibitors; Infusions, Intra-Arterial; Ion Channel Gating; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channels; Pyrazines; Quinolines; Receptors, Purinergic P1; Theophylline | 1997 |
Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Enzyme Inhibitors; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Rabbits | 1997 |
Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Antigens, CD; Aspirin; Blood Platelets; Cerebral Hemorrhage; Cerebrovascular Disorders; Collagen; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; Myocardial Infarction; P-Selectin; Paraplegia; Plasminogen Activators; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; Prospective Studies; Receptors, Very Late Antigen; Ristocetin; Tetraspanin 29; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator; Vitronectin | 1998 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Aspirin; Blood Platelets; Cardiovascular Diseases; Cilostazol; Death, Sudden, Cardiac; Disease Susceptibility; Dose-Response Relationship, Drug; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles | 1998 |
Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction. The GUSTO-III Platelet Substudy.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Cell Surface; Thrombolytic Therapy | 1998 |
Interstitial ATP level and degradation in control and postmyocardial infarcted rats.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Heart; Hypoxanthine; In Vitro Techniques; Inosine; Intracellular Fluid; Male; Microdialysis; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Time Factors; Xanthine | 1998 |
Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Antibodies, Monoclonal; Blood Platelets; Case-Control Studies; Collagen; Female; Flow Cytometry; Hemostatics; Humans; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Cell Surface; Receptors, Cytoadhesin; Ristocetin; Thrombin | 1998 |
Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Ischemic Preconditioning; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Antagonists; Rabbits; Theophylline | 1998 |
Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Aspirin; Coronary Vessels; Diabetes Mellitus; Drug Therapy, Combination; Female; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Aggregation; Predictive Value of Tests; Prothrombin; Recombinant Proteins; Recurrence; Risk Factors; Smoking; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1998 |
Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability.
Topics: Acute Disease; Adenosine Diphosphate; Adrenergic Agonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Angina, Unstable; Blood Coagulation Tests; Case-Control Studies; Coronary Disease; Epinephrine; Female; Humans; Lasers; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Scattering, Radiation | 1998 |
Arterial thrombosis in heart failure.
Topics: Adenosine Diphosphate; Coronary Thrombosis; Epinephrine; Fibrinogen; Heart Failure; Hemorheology; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Edema; Vasoconstrictor Agents; von Willebrand Factor | 1998 |
Clopidogrel: a novel antiplatelet agent.
Topics: Adenosine Diphosphate; Aspirin; Clopidogrel; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 1999 |
c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy co
Topics: Abciximab; Adenosine Diphosphate; Adsorption; Adult; Antibodies, Monoclonal; Anticoagulants; Blood Flow Velocity; Blood Platelets; Cell Culture Techniques; Endothelium, Vascular; Fibrinogen; Glass; Hemorheology; Humans; Immunoglobulin Fab Fragments; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Time Factors; Umbilical Veins; von Willebrand Factor | 2000 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate | 2000 |
Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study.
Topics: Adenosine Diphosphate; Aged; Blood Coagulation Tests; Electric Impedance; Filtration; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Predictive Value of Tests; Risk; Stroke; Time Factors; Wales | 2001 |
Mitochondrial ATPase and high-energy phosphates in failing hearts.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiac Pacing, Artificial; Coronary Circulation; Disease Models, Animal; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Infusions, Intravenous; Magnetic Resonance Spectroscopy; Mitochondria, Heart; Myocardial Infarction; Organ Size; Phosphocreatine; Protein Subunits; Proton-Translocating ATPases; Swine; Ventricular Remodeling | 2001 |
Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Analysis of Variance; Animals; Calcium; Drug Synergism; Enzyme Inhibitors; Magnesium; Male; Models, Animal; Myocardial Infarction; Myocardium; Purinergic P1 Receptor Antagonists; Rabbits; Theophylline | 2002 |
Beneficial effect of practolol in preventing adrenaline-induced systemic and myocardial metabolic changes.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Dogs; Epinephrine; Fatty Acids, Nonesterified; Female; Glucose; Histocytochemistry; Lactates; Male; Myocardial Infarction; Myocardium; Practolol; Triiodothyronine | 1979 |
Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis.
Topics: Adenosine Diphosphate; Blood Coagulation; Chlorpromazine; Depression, Chemical; Dose-Response Relationship, Drug; Hemoglobins; Hemolysis; Myocardial Infarction; Platelet Aggregation; Rheology | 1979 |
Inhibition of ADP-induced platelet aggregation by dipyrone in patients with acute myocardial infarction.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Aged; Aminopyrine; Dipyrone; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Time Factors | 1979 |
Arachidonate versus ADP-induced platelet aggregation in acute myocardial infarction.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Aged; Arachidonic Acids; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation | 1979 |
Effects of all cis-5,8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation.
Topics: Adenosine Diphosphate; Arachidonic Acids; Collagen; Drug Interactions; Eicosanoic Acids; Fatty Acids, Unsaturated; Feeding Behavior; Humans; Inuit; Linoleic Acids; Linolenic Acids; Myocardial Infarction; Oleic Acids; Platelet Aggregation; Prostaglandins D; Prostaglandins E; Prostaglandins F, Synthetic; Thromboxanes | 1979 |
[Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
Topics: Adenosine Diphosphate; Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Platelet Aggregation | 1979 |
The effect of hypokinesis on blood clotting in rabbits.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Collagen; Electrocardiography; Epinephrine; Hematocrit; Male; Movement; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Restraint, Physical | 1978 |
[Influence of acute exertion and physical training on platelet function of the coronary patient].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Adhesiveness; Platelet Aggregation | 1976 |
Peripheral venous platelet aggregates in patients with unstable angina pectoris and acute myocardial infarction.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Angina Pectoris; Aspirin; Blood Cell Count; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation | 1977 |
Platelet adhesiveness in myocardial infarction in relation to clinical course.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Aged; Catecholamines; Humans; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Prognosis | 1976 |
Effect of emotional stress on platelet aggregation in humans.
Topics: Adenosine Diphosphate; Adult; Epinephrine; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation; Stress, Psychological | 1976 |
Effect of ischemia and infarction on regional content of adenine nucleotides and derivatives in canine left ventricle.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Coronary Disease; Dogs; Female; Heart Ventricles; Hypoxanthines; Inosine; Male; Myocardial Infarction; Myocardium | 1976 |
[Evaluation of the filtration pressure of the platelet aggregates in a group of coronary patients].
Topics: Adenosine Diphosphate; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation | 1976 |
Platelets and drugs.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Blood Platelets; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Factor 3; Thrombocytopenia; Thromboembolism | 1976 |
Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Creatine; Dogs; Energy Metabolism; Fluoresceins; Lactates; Ligation; Mercury; Myocardial Infarction; Myocardium; Organomercury Compounds; Phosphocreatine; Phosphorus; Pyruvates; Water-Electrolyte Balance | 1975 |
Technique for the estimation of abnormal disaggregation patterns in platelets.
Topics: Adenosine Diphosphate; Blood Platelet Disorders; Humans; Medical Laboratory Science; Myocardial Infarction; Platelet Aggregation | 1975 |
Enhanced platelet aggregation as a risk factor for vascular disease and its thromboembolic complications.
Topics: Adenosine Diphosphate; Arteriosclerosis; Collagen; Epinephrine; Humans; Myocardial Infarction; Platelet Aggregation; Thromboembolism | 1975 |
Global depletion of myocardial norepinephrine and ATP after left coronary artery occlusion in rats.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Epinephrine; Female; Male; Myocardial Infarction; Myocardium; Norepinephrine; Propranolol; Rats; Rats, Wistar; Verapamil | 1992 |
Platelet response to the aggregatory effect of platelet activating factor (PAF) ex vivo in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Drug Resistance; Epoprostenol; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Time Factors | 1991 |
Thrombocytes and coronary heart disease.
Topics: Adenosine Diphosphate; Angina Pectoris; Arteriosclerosis; Blood Platelets; Coronary Disease; Humans; Models, Cardiovascular; Myocardial Infarction; Platelet Aggregation | 1991 |
Changes in myocardial mitochondrial respiration after ligation of the coronary artery in pigs.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cell Fractionation; Coronary Disease; Coronary Vessels; Female; Glutamates; Glutamic Acid; Ligation; Male; Mitochondria, Heart; Myocardial Infarction; Oxygen Consumption; Succinates; Succinic Acid; Swine | 1990 |
Determination of creatine kinase in the sera of patients with myocardial infarction by a rho-nitrophenylglyoxal method.
Topics: Adenosine Diphosphate; Colorimetry; Creatine Kinase; Female; Humans; Male; Myocardial Infarction; Nitrophenylgalactosides; Phosphocreatine | 1990 |
Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction.
Topics: Adenosine Diphosphate; Angina Pectoris; Angina, Unstable; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombin; Time Factors | 1990 |
Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.
Topics: Adenosine Diphosphate; Anistreplase; Aspirin; Collagen; Fibrinolytic Agents; Humans; In Vitro Techniques; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Streptokinase; Tissue Plasminogen Activator | 1990 |
[Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; beta-Thromboglobulin; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Recurrence; Thrombolytic Therapy; Thromboxane B2 | 1990 |
Effects of the free radical generating system FeCl3/ADP on reperfusion arrhythmias of rat hearts and electrical activity of canine Purkinje fibres.
Topics: Action Potentials; Adenosine Diphosphate; Animals; Arrhythmias, Cardiac; Chlorides; Ferric Compounds; Free Radicals; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Organ Culture Techniques; Purkinje Fibers; Rats; Rats, Inbred Strains | 1990 |
[Agonist-induced platelet adhesion: use of the method in patients with myocardial infarction].
Topics: Adenosine Diphosphate; Epinephrine; Humans; Male; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Prostaglandin Endoperoxides, Synthetic | 1990 |
Relationship between platelet aggregation and plasma beta-thromboglobulin levels in arterio-vascular and renal diseases.
Topics: Adenosine Diphosphate; Adolescent; Adult; Age Factors; Aged; Beta-Globulins; beta-Thromboglobulin; Cerebrovascular Disorders; Female; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Uremia | 1985 |
Increased platelet-derived mitogenic activity in plasma of young patients with coronary atherosclerosis.
Topics: Adenosine Diphosphate; Adult; alpha-Macroglobulins; beta-Thromboglobulin; Blood Platelets; Coronary Artery Disease; Coronary Vessels; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Phenotype; Platelet Aggregation; Platelet Factor 4; Platelet-Derived Growth Factor | 1986 |
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Topics: Adenosine Diphosphate; Aspirin; Bleeding Time; Emergencies; Fibrin Fibrinogen Degradation Products; Hematocrit; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 1989 |
Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Angina, Unstable; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2 | 1989 |
The relation between platelet reactivity and coronary angiographic findings in young female survivors of acute myocardial infarction.
Topics: Adenosine Diphosphate; Adult; Angiocardiography; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Humans; Middle Aged; Myocardial Infarction; Platelet Factor 4 | 1986 |
Platelet prostacyclin binding in coronary artery disease.
Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Blood Platelets; Coronary Disease; Cyclic AMP; Epoprostenol; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation; Receptors, Epoprostenol; Receptors, Prostaglandin | 1986 |
[Calcium metabolism of the thrombocytes in ischemic heart disease].
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Calcium; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Time Factors | 1988 |
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.
Topics: Adenosine Diphosphate; Adult; Death, Sudden; Epinephrine; Hematocrit; Humans; In Vitro Techniques; Male; Myocardial Infarction; Platelet Aggregation; Platelet Count; Posture; Time | 1987 |
[Effect of polyunsaturated fatty acids on the functional properties of the thrombocytes and on lipid peroxidation in ischemic heart disease patients].
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Chronic Disease; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Fatty Acids, Unsaturated; Humans; Lipid Peroxides; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Physical Exertion; Platelet Aggregation; Time Factors; Vitamin E | 1987 |
Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Pressure; Coronary Disease; Dogs; Energy Metabolism; Female; Kinetics; Male; Myocardial Infarction; Myocardium; Necrosis | 1986 |
[Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Blood Platelets; Calcium; Coronary Artery Disease; Coronary Disease; Cytoplasm; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1986 |
ADP-induced platelet aggregation in young female survivors of acute myocardial infarction and their female controls.
Topics: Adenosine Diphosphate; Adult; Female; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation | 1985 |
Myocardial adenine pool depletion and recovery of mechanical function following ischemia.
Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Coronary Circulation; Male; Myocardial Infarction; Myocardium; Perfusion; Rats; Rats, Inbred Strains; Regional Blood Flow; Time Factors | 1985 |
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.
Topics: Adenosine Diphosphate; Adolescent; Adult; Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Cell Count; Blood Specimen Collection; Cardiovascular Diseases; Formaldehyde; Humans; In Vitro Techniques; Infusions, Parenteral; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Thrombin; Thromboembolism | 1974 |
Metabolic control of rat heart glycolysis after acute ischaemia. Fluoracetate treatment and thyroid interactions.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Fluoroacetates; Fructosephosphates; Glucosephosphate Dehydrogenase; Glucosephosphates; Glyceraldehyde; Glycerolphosphate Dehydrogenase; Glycerophosphates; Glycolysis; Hexokinase; Hypothyroidism; Hypoxia; Ischemia; Male; Myocardial Infarction; Myocardium; Phosphates; Phosphofructokinase-1; Phosphogluconate Dehydrogenase; Pyruvate Kinase; Pyruvates; Rats; Thyroid Gland; Thyroid Hormones | 1971 |
Platelet electrophoresis: the present position.
Topics: Adenosine Diphosphate; Age Factors; Blood Platelets; Coronary Disease; Electrophoresis; Humans; Lipoproteins, LDL; Methods; Myocardial Infarction; Platelet Adhesiveness | 1974 |
[Pathogenetic aspects of cellular hemostasis in ischemic heart disease].
Topics: Adenosine Diphosphate; Angina Pectoris; Arteriosclerosis; Basophils; Blood Coagulation; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation | 1974 |
[Platelet aggregates studied by the Swank method of microfiltration under pressure. Pharmacological and pathological applications].
Topics: Adenosine Diphosphate; Anticoagulants; Blood Coagulation Disorders; Citrates; Female; Filtration; Humans; Infections; Myocardial Infarction; Norepinephrine; Platelet Adhesiveness; Platelet Aggregation; Poisoning; Pre-Eclampsia; Pregnancy; Pulmonary Embolism; Sepsis; Thrombosis; Wounds and Injuries | 1974 |
Evidence for two separate effects of adenosine diphosphate on human platelets.
Topics: Adenosine Diphosphate; Blood Platelets; Cell Movement; Cyanides; Electrophoresis; Humans; Myocardial Infarction; Phosphatidylcholines; Plasma; Potassium | 1972 |
[Energy metabolism in myocardial diseases].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Humans; Middle Aged; Myocardial Infarction | 1972 |
Density gradient separation of human platelets from plasma and the role of plasma in adenosine diphosphate induced platelet electrophoretic mobility changes.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Centrifugation, Density Gradient; Electrophoresis; Fibrinogen; Humans; Myocardial Infarction; Phosphatidylcholines; Plasma; Platelet Adhesiveness | 1972 |
Metabolic changes in infarcted and non-infarcted myocardium during the postinfarction period.
Topics: Acid Phosphatase; Adenosine Diphosphate; Adenosine Triphosphate; Anabolic Agents; Animals; Disease Models, Animal; Dogs; Glucuronidase; Heart; Heart Ventricles; Lactates; Myocardial Contraction; Myocardial Infarction; Myocardium; Norepinephrine; Phosphocreatine; Proline; Pyruvates; Time Factors | 1972 |
[Energy metabolism of right ventricular myocardium following section of the left coronary artery].
Topics: Acute Disease; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Vessels; Dogs; Glycogen; Glycolysis; Heart Ventricles; Mitochondria, Muscle; Myocardial Infarction; Myocardium; Oxidative Phosphorylation; Oxygen Consumption; Phosphocreatine | 1973 |
Platelet abnormalities in ischemic heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Animals; Arteriosclerosis; Blood Coagulation Tests; Blood Platelet Disorders; Cattle; Chromium Radioisotopes; Collagen; Coronary Disease; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness | 1973 |
[Thrombocytes, thrombin, thrombosis and heart infarct].
Topics: Adenosine Diphosphate; Blood Platelets; Humans; Myocardial Infarction; Platelet Adhesiveness; Thrombin; Thrombosis | 1973 |
Biochemical changes in non-infarcted heart muscle following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Pressure; Dogs; Heart; Lactates; Myocardial Infarction; Myocardium; Phosphocreatine; Pyruvates; Time Factors | 1973 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrine; Glomerulonephritis; Heart Valve Prosthesis; Humans; Hypertension, Malignant; Ischemia; Myocardial Infarction; Platelet Adhesiveness; Postoperative Complications; Prostaglandins; Pyrimidines; Thromboembolism; Thrombophlebitis; Thrombosis; Xanthines | 1974 |
Platelet studies in patients with coronary artery disease and in their relatives.
Topics: Adenosine Diphosphate; Adult; Age Factors; Aged; Angiography; Blood Platelets; Cell Movement; Cholesterol; Coronary Angiography; Coronary Disease; Electrocardiography; Electrophoresis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Triglycerides | 1972 |
Increased coronary venous inorganic phosphate concentrations during experimental myocardial ischemia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biopsy; Coronary Vessels; Dogs; Lactates; Ligation; Myocardial Infarction; Myocardium; Phosphates; Potassium; Rats; Time Factors; Veins | 1972 |
Biochemical changes in non-infarcted heart muscle following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Biopsy; Carbon Isotopes; Coronary Vessels; Disease Models, Animal; Dogs; Heart Ventricles; Hemodynamics; Hydroxyproline; Lactates; Ligation; Myocardial Infarction; Myocardium; Norepinephrine; Oxygen Consumption; Phosphocreatine; Pyruvates; Time Factors; Water | 1971 |
Changes in myocardial high energy phosphate levels and left ventricular function after coronary artery occlusion in anaesthetized dogs.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Pressure; Coronary Vessels; Dogs; Heart; Heart Rate; Heart Ventricles; Lactates; Ligation; Myocardial Infarction; Myocardium; Phosphates; Phosphocreatine; Pyruvates; Time Factors | 1971 |
Functional compartmentation of ATP and creatine phosphate in heart muscle.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Biopsy; Coronary Disease; Coronary Vessels; Creatine Kinase; Dogs; Energy Transfer; Heart; Ischemia; Kinetics; Lactates; Ligation; Mitochondria, Muscle; Myocardial Infarction; Myocardium; Phosphocreatine; Pyruvates | 1970 |